| abstract |
Use of pipamperone or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment of a mood disorder or an anxiety disorder, wherein said pipamperone or a pharmaceutically acceptable salt is to be administered to a patient in a daily dose in the range between 5 and 15 mg of the active ingredient, and where a second compound is to be administered simultaneously, separately or sequentially with respect to said pipamperone to increase the therapeutic effect of said second compound, said second compound being selected from the group consisting of: a selective serotonin, noradrenaline, and dopamine reuptake inhibitor (SNDRI), a selective serotonin and norepinephrine reuptake inhibitor (SNRI) and a selective serotonin reuptake inhibitor (SSRI). |